MedTrace Logo

Post-marketing Clinical Follow-up for Long-term Use of Intranasal Kinetic Oscillation in Subjects With Chronic Migraine

NCT05843721 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2025-09-12

No results posted yet for this study

Summary

An non controlled, long term, multi center investigation

Conditions

  • Chronic Migraine

Interventions

DEVICE

KOS (Intranasal kinetic oscillation stimulation)

Treatment is 10 minutes in each nasal cavity. Totally 2 x 10 minutes per treatment.

Sponsors & Collaborators

  • Chordate Medical

    lead INDUSTRY

Principal Investigators

  • Peter J Goadsby, Prof,MD,PhD · Wellcome Foundation Building, Denmark Hill Campus King's College London

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-08
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Germany
  • Israel
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05843721 on ClinicalTrials.gov